Dr Absar Khalid Mir, Dr Mohammad Ahmad Abbasi, Dr Laiba Mustansar Sahi, Dr Samana Batool, Dr Muhammad Bilal Anwar, Dr Tehreem Ali, Dr Abeera Kazmi, Dr Israa Alam, and Dr Muhammad Ali Hassan. “EVALUATING THE RISK-BENEFIT PROFILE OF RIVAROXABAN VERSUS WARFARIN IN STROKE PREVENTION AMONG ELDERLY PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION; A RETROSPECTIVE COHORT STUDY”. Journal of Population Therapeutics and Clinical Pharmacology 31, no. 6 (June 12, 2024): 1059–1065. Accessed December 21, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/6611.